[Low grade non-Hodgkin's lymphoma after combined therapy for Hodgkin's disease].
The most serious complication of curative therapy for Hodgkin's disease is the development of a second malignancy. A patient who developed a low grade non-Hodgkin's lymphoma three years and a half after combined-modality therapy for Hodgkin's disease, is described. It is exceptional this type of non-Hodgkin's lymphoma as a second neoplasm after cytotoxic treatment for Hodgkin's disease. Pathogenic relationships between both processes are discussed.
Raya Sánchez
J M
JM
Servicio de Hematología y Hemoterapia, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife.
González Brito
G
G
Hernández Nieto
L
L
Brito Barroso
M L
ML
Alvarez Argüelles
H
H
Jorge Hernández
J A
JA
Martín Herrera
A
A
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001706:Biopsy; D005260:Female; D006119:Groin; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000139:chemically induced*; D008875:Middle Aged; D009333:Neck; D016609:Neoplasms, Second Primary / Q000139:chemically induced*
Linfoma no Hodgkin de bajo grado tras terapéutica combinada por enfermedad de Hodgkin.